Best Growth Stocks To Keep An Eye On - October 22nd

Key Points

• MarketBeat identified five growth stocks to watch: Prologis (PLD), Teledyne Technologies (TDY), Ascendis Pharma (ASND), K&F Growth Acquisition Corp. II (KFII), and Hamilton Lane (HLNE), selected for their recent trading volume.
• The companies represent diverse growth themes, including logistics real estate and data centers at Prologis, industrial imaging and semiconductor technologies at Teledyne, and rare-disease therapies at Ascendis Pharma.
• KFII is a blank-check company seeking a business combination, while Hamilton Lane is a private-equity firm investing across sectors such as technology, health care, real estate, and industrials.

Prologis, Teledyne Technologies, Ascendis Pharma A/S, K&F GROWTH ACQUISITION CORP. II, and Hamilton Lane are the five Growth stocks to watch today, according to MarketBeat's stock screener tool. Growth stocks are shares of companies expected to grow their revenue and earnings faster than the overall market or their industry. Investors often accept higher valuations and greater risk for these stocks because they anticipate strong future expansion, although growth stocks may pay little or no dividends. These companies had the highest dollar trading volume of any Growth stocks within the last several days.

Prologis (PLD)

Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. At March 31, 2024, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 1.2 billion square feet (115 million square meters) in 19 countries.

Read Our Latest Research Report on PLD

Teledyne Technologies (TDY)

Teledyne Technologies Incorporated, together with its subsidiaries, provides enabling technologies for industrial growth markets in the United States and internationally. Its Digital Imaging segment provides visible spectrum sensors and digital cameras; and infrared, ultraviolet, visible, and X-ray spectra; as well as micro electromechanical systems and semiconductors, including analog-to-digital and digital-to-analog converters.

Read Our Latest Research Report on TDY

Ascendis Pharma A/S (ASND)

Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapies for unmet medical needs. It offers SKYTROFA for treating patients with growth hormone deficiency (GHD). The company is also developing a pipeline of three independent endocrinology rare disease product candidates in clinical development, as well as focuses on advancing oncology therapeutic candidates.

Read Our Latest Research Report on ASND

K&F GROWTH ACQUISITION CORP. II (KFII)

We are a blank check company incorporated on July 2, 2024, as a Cayman Islands exempted company and formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, which we refer to throughout this prospectus as our initial business combination.

Read Our Latest Research Report on KFII

Hamilton Lane (HLNE)

Hamilton Lane Incorporated is a private equity firm specializing in early venture, emerging growth, turnaround, middle market, mature, mid-venture, bridge, buyout, distressed/vulture, loan, mezzanine in growth capital companies. It prefers to invest in energy, industrials, consumer discretionary, health care, real estate, information technology, utilities, and consumer services.

Read Our Latest Research Report on HLNE

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.